Log In
BCIQ
Print this Print this
 

CSI Glucagon

  Manage Alerts
Collapse Summary General Information
Company Xeris Pharmaceuticals Inc.
DescriptionRoom temperature-stable glucagon solution delivered continuously via OmniPod infusion patch pump technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHypoglycemia
Indication DetailsPrevent severe, persistent hypoglycemia related to congenital hyperinsulinism
Regulatory Designation U.S. - Orphan Drug (Prevent severe, persistent hypoglycemia related to congenital hyperinsulinism);
EU - Orphan Drug (Prevent severe, persistent hypoglycemia related to congenital hyperinsulinism)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today